Lamprell announced that Ellis Armstrong has decided not to stand for re-election as a Director at the 2018 Annual General Meeting. Dr. Armstrong has been an independent Non-executive Director for Lamprell since 27 May 2013 and he, together with the Lamprell Board, recognise the importance of refreshing its independent directors at appropriate times. With effect from 1 January 2018, Mr. James Dewar will replace Dr. Armstrong in the role of chair of the Audit & Risk Committee. Until the 2018 AGM, Dr. Armstrong will continue in his roles as the company's Senior Independent Director and as a member of the company's principal board committees.